The GLP-1 RAs Wegovy, Ozempic, Mounjaro, and Zepbound have taken up more real estate on the US map in some areas than others. Click to find out more.
Patient Care Online March 2024
Semaglutide was associated with a lower risk of first-time and recurrent suicidal ideations in patients with obesity or overweight or T2D, according to new study.
In an open letter to the public, Lilly decries use of tirzepatide products Mounjaro and Zepbound for nonmedical purposes and warns of counterfeit formulations.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears First Blood Test to Rule Out Alzheimer-Related Pathology in Primary Care
2
FDA Accepts MannKind sBLA for Inhaled Insulin for Children and Adolescents with Diabetes
3
GLP-1 RAs Linked to Atypical Uptake on PET-CT Scans, Raising Interpretation Challenges
4
Kabiul Haque, MD, on Effective Management of Peripheral Arterial Disease in Primary Care
5
